Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Edwin Gomez

Psychiatry Weston, FL Medical Doctor

NPI 1780775098 CMS profile 80823

1040 Weston Rd, Suite 210, Weston, FL 33326

Open in the dashboard

General payments

$5,578

122 records reported · program years 2019–2025

Research payments

$869

Paid to them · 7 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$24,914,862 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Edwin Gomez of Weston, FL is reported in the CMS Open Payments database as having received $5,578 across 122 general payments and $869 in research payments paid to them. Separately, studies naming them as principal investigator received $24,914,862 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,639 12
2025 Research $869 7
2024 General $1,848 10
2023 General $120 3
2022 General $245 2
2021 General $247 11
2020 General $560 27
2019 General $920 57

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Edwin Gomez
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Edwin Gomez were reported at $1,639. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Edwin Gomez Psychiatry median Middle half National median
2019 $920 $184 $59–$605 $163
2020 $560 $119 $36–$372 $114
2021 $247 $143 $43–$576 $132
2022 $245 $153 $50–$590 $149
2023 $120 $170 $56–$651 $160
2024 $1,848 $179 $57–$673 $164
2025 $1,639 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Neurocrine Biosciences, Inc. $1,534 13 payments
  2. Boehringer Ingelheim Pharmaceuticals, Inc. $1,223 11 payments
  3. E.R. Squibb & Sons, L.L.C. $754 2 payments
  4. Otsuka America Pharmaceutical, Inc. $379 17 payments
  5. Alkermes, Inc. $365 19 payments
  6. Indivior Inc. $364 16 payments
  7. Janssen Pharmaceuticals, Inc $224 13 payments
  8. ITI, Inc. $177 7 payments
  9. Allergan Inc. $125 8 payments
  10. Novartis Pharmaceuticals Corporation $120 1 payment
  11. Other $313 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,888 112 payments
  2. Travel and Lodging $1,962 8 payments
  3. Consulting Fee $720 1 payment
  4. Education $9 1 payment
Products named General payments · program years 2019–2025
  1. COBENFY $720 1 payment
  2. ABILIFY MAINTENA $345 15 payments
  3. ARISTADA INITIO $345 18 payments
  4. ARISTADA Cns $345 18 payments
  5. ARISTADA Cns $345 18 payments
  6. ARISTADA Cns $345 18 payments
  7. ARISTADA Cns $345 18 payments
  8. SUBLOCADE $217 8 payments
  9. INVEGA SUSTENNA $206 12 payments
  10. CAPLYTA $177 7 payments
  11. Other $993 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. AbbVie, Inc. $869 7 payments

Records

129 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record